Risks and misconceptions of guidelines in medicine and palliative medicine in particular

Progress in Palliative Care

Volumn 10, Issue 6, 2002, Pages 275-279

  Lübbe, Andreas S ^a  

^a Cecilien Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; CANCER THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; EMPATHY; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH INSURANCE; HUMAN; INTERPERSONAL COMMUNICATION; INTUITION; MANAGED CARE; MEDICAL DECISION MAKING; PALLIATIVE THERAPY; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

EID: 0036977348     PISSN: 09699260     EISSN: None     Source Type: Journal    
DOI: 10.1080/09699260.2002.11746643     Document Type: Review

References (17)

1. Sackett DL, Rosenberg WM, Muir Gray JA, Brian Haynes R, Scott Richardson W. Evidence-based medicine: what it is and what it isn't. BMJ 1996;312:71-2.
2. Rosenberg W, Donald A. Evidence-based medicine: an approach to clinical problem-solving. BMJ 1995;310;1122-6, 1995.
3. AWMF online. http://www.uni.duesseldorf.de/WWW/AWMF/awmfleit.htm
4. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
5. Scriba, PC. Immer dringender: Evaluation von Gesundheitszielen und Leitlinien. Dt Ärzteblatt 1999;96:B-696-8.
6. Kolkmann FW. Qualitätsstandards in der Onkologie aus Sicht der Bundesärztekammer. Forum-DKG 1995;10:B-71-372.
7. Sackett, Richardson, Rosenberg, Haynes. Evidenzbasierte Medizin, EBM- Umsetzung und -Vermittlung, Munich: Zuckschwerdt-Verlag; 1998.
8. Ollenschläger G, Schott G. Leitlinien und Evidenzbasierte Medizin in Deutschland: Aktueller Stand, Erfahrungen der Deutschen Krebsgesllschaft und Ausblick. Der Onkologe 1999;5:826-9.
9. McAlister F, Straus SE, Guyatt G, Haynes RB for the Evidence-Based Medicine Working Group. Users' guidelines to the medical literature: XX. Integrating research evidence with the care of the individual patient. JAMA 2000;283:2829-36.
10. Goodwin JS. Geriatrics and the limits of modern medicine. N Engl J Med 2000;340:1283-5.
11. MacDougall RH, Munro AZ, Wilson JA. Palliation in head and neck cancer. In: Doyle D, Hanks G, McDonnell N, editors. The Oxford Textbook of Palliative Medicine. 2nd ed. Oxford: Oxford University Press; 1998. pp 677-89.
12. Weinstein MC, Fineberg HV, Elstein AS, editors. Clinical Decision Analysis. Philadelphia: WB Saunders; 1980.
13. Plante DA, Piccirillo JF, Sofferman RA. Decision analysis of treatment options in pyriform sinus carcinoma. Med Decis Making 1987;74-83.
14. Cottin V, Aroin D, Lasset C, et al. Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole. Ann Oncol 1999;10:809-15.
15. Straus SE, Sackett DL. Applying evidence to the individual patient. Ann Oncol 1999;10:29-32.
16. Munro AJ, Sebag-Montefiore D. Opportunity costs - a neglected aspect of cancer treatment. Br J Cancer 1992;65:309-10.
17. Lauterbach K. Vorurteile abbauen. Dt Ärzteblatt 1999;96:A-2128-31 (Heft 34-35)